A SPECTROSCOPIC STUDY OF THE CONFORMATIONS OF ACTIVE AND LATENT FORMS OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1

被引：0

作者：

DWIVEDI, AM ^{[1
]}

WOODESHICK, RW ^{[1
]}

WALTON, HL ^{[1
]}

RACANELLI, AL ^{[1
]}

REILLY, TM ^{[1
]}

机构：

[1] DUPONT MERCK PHARMACEUT CO,WILMINGTON,DE 19880

来源：

THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1271 / 1271

页数：1

共 50 条

[21] DETERMINANTS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY IN TREATED NIDDM AND ITS RELATION TO A POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE [J].

PANAHLOO, A ;

MOHAMEDALI, V ;

LANE, A ;

GREEN, F ;

HUMPHRIES, SE ;

YUDKIN, JS .

DIABETES, 1995, 44 (01) :37-42

[22] THE MECHANISM OF THE REACTION BETWEEN HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE PLASMINOGEN-ACTIVATOR [J].

LINDAHL, TL ;

OHLSSON, PI ;

WIMAN, B .

BIOCHEMICAL JOURNAL, 1990, 265 (01) :109-113

[23] ITO CELLS SYNTHESIZE PLASMINOGEN-ACTIVATOR INHIBITOR-1 - REGULATION BY CORTICOSTEROIDS AND PLASMINOGEN-ACTIVATOR [J].

KNITTEL, T ;

FELLMER, P ;

RAMADORI, G .

GASTROENTEROLOGY, 1995, 108 (04) :A1100-A1100

[24] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS THE PRIMARY INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PREGNANCY PLASMA [J].

JORGENSEN, M ;

PHILIPS, M ;

THORSEN, S ;

SELMER, J ;

ZEUTHEN, J .

THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) :872-878

[25] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS [J].

SUMINSKI, R ;

DASILVA, S ;

SMITH, M ;

ERBEY, J .

DIABETES, 1994, 43 :A197-A197

[26] MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN PLASMA [J].

ALESSI, MC ;

JUHANVAGUE, I ;

DECLERCK, PJ ;

COLLEN, C .

THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) :475-475

[27] ISOLATION AND CHARACTERIZATION OF REACTIVATED FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) [J].

DECLERCK, PJ ;

DEMOL, M ;

COLLEN, D .

THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) :653-653

[28] Engineering of conformations of plasminogen activator inhibitor-1 -: A crucial role of β-strand 5A residues in the transition of active form to latent and substrate forms [J].

Kirkegaard, T ;

Jensen, S ;

Schousboe, SL ;

Petersen, HH ;

Egelund, R ;

Andreasen, PA ;

Rodenburg, KW .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (02) :577-586

[29] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY [J].

DAWSON, S ;

HAMSTEN, A ;

WIMAN, B ;

HENNEY, A ;

HUMPHRIES, S .

ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :183-190

[30] A spectroscopic study of the structures of latent, active and reactive-center-cleaved type-1 plasminogen-activator inhibitor [J].

Eur J Biochem, 3 (550)

← 1 2 3 4 5 →